Gilead Sciences Inc. (GILD) on Thursday reported first-quarter results with profit rising from last year, supported by higher product sales and improved operating income.
Total revenue increased to $6.96 billion in the first quarter of 2026 from $6.67 billion in the same period last year.
Net income climbed to $2.02 billion, or $1.61 per share, compared with $1.32 billion, or $1.04 per share, in the first quarter of 2025.
Gilead also raised its 2026 product sales guidance to a range of $30.0 billion to $30.4 billion, up from its prior outlook of $29.6 billion to $30.0 billion.
GILD is currently trading after hours at $131.79, down $2.27 or 1.69 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.